Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Autoimmune Disorders

  Free Subscription


19.02.2024

1 Ann Neurol
2 BMC Neurol
14 Diabetes Res Clin Pract
5 Intern Med
1 J Autoimmun
1 J Nephrol
2 J Neuroimmunol
1 J Neurol
2 J Rheumatol
5 Mult Scler
2 N Engl J Med
3 Neurology
1 PLoS Comput Biol
5 PLoS One
3 Proc Natl Acad Sci U S A
1 Semin Hematol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Neurol

  1. CHOMYK A, Kucinski R, Kim J, Christie E, et al
    Transcript Profiles of Microglia/Macrophage Cells at the Borders of Chronic Active and Subpial Gray Matter Lesions in Multiple Sclerosis.
    Ann Neurol. 2024 Feb 12. doi: 10.1002/ana.26877.
    PubMed         Abstract available


    BMC Neurol

  2. GHAZANFARI HASHEMI M, Talebi V, Abbasi Kasbi N, Abbasi M, et al
    T1 hypointense brain lesions in NMOSD and its relevance with disability: a single institution cross-sectional study.
    BMC Neurol. 2024;24:62.
    PubMed         Abstract available

  3. MCCALLION J, Borsi A, Noel W, Lee J, et al
    Systematic review of the patient burden of generalised myasthenia gravis in Europe, the Middle East, and Africa.
    BMC Neurol. 2024;24:61.
    PubMed         Abstract available


    Diabetes Res Clin Pract

  4. CHAUDHRY UAR, Carey IM, Critchley JA, DeWilde S, et al
    A matched cohort study evaluating the risks of infections in people with type 1 diabetes and their associations with glycated haemoglobin.
    Diabetes Res Clin Pract. 2024;207:111023.
    PubMed         Abstract available

  5. SCARR D, Lovblom E, Ye H, Liu H, et al
    Ketone production and excretion even during mild hyperglycemia and the impact of sodium-glucose co-transporter inhibition in type 1 diabetes.
    Diabetes Res Clin Pract. 2024;207:111031.
    PubMed         Abstract available

  6. SUZUKI Y
    Case report: Tirzepatide for mitochondrial diabetes mellitus with a mutation at position 3271 and transient GAD antibody positivity.
    Diabetes Res Clin Pract. 2024;207:111035.
    PubMed        

  7. LONGO M, Scappaticcio L, Signoriello S, Caruso P, et al
    Glucose control during breakthrough SARS-CoV-2 infections in vaccinated patients with type 1 diabetes.
    Diabetes Res Clin Pract. 2024;207:111044.
    PubMed         Abstract available

  8. SMITH C, Cristello Sarteau A, Qu X, Noe V, et al
    A conceptual model of the continuous glucose monitoring integration process for older adults with diabetes developed using participatory systems science methods.
    Diabetes Res Clin Pract. 2024;207:111053.
    PubMed         Abstract available

  9. WANG D, Hou X, Huang J, Sun J, et al
    Incidence and trends of type 1 diabetes before and after 2000 in the Western Pacific Region: A systematic review and meta-analysis.
    Diabetes Res Clin Pract. 2024;207:111055.
    PubMed         Abstract available

  10. PANCHAL K, Lawson C, Chandramouli C, Lam C, et al
    Diabetes and risk of heart failure in people with and without cardiovascular disease: systematic review and meta-analysis.
    Diabetes Res Clin Pract. 2024;207:111054.
    PubMed         Abstract available

  11. SHIMONY H, Miller L, Reich P, Banull NR, et al
    Pediatric diabetes mellitus hospitalizations and COVID-19 pandemic response measures.
    Diabetes Res Clin Pract. 2024;207:111060.
    PubMed         Abstract available

  12. MOZZILLO E, Marigliano M, Cuccurullo I, Berchielli F, et al
    Maintaining the gluten-free diet: The key to improve glycemic metrics in youths with type 1 diabetes and celiac disease.
    Diabetes Res Clin Pract. 2024;207:111074.
    PubMed         Abstract available

  13. TRAN T, Igudesman D, Burger K, Crandell J, et al
    Eating behaviors and estimated body fat percentage among adolescents with type 1 diabetes.
    Diabetes Res Clin Pract. 2024;207:111070.
    PubMed         Abstract available

  14. COBRY EC, Pyle L, Karami AJ, Sakamoto C, et al
    Impact of 6-months of an advanced hybrid closed-loop system on sleep and psychosocial outcomes in youth with type 1 diabetes and their parents.
    Diabetes Res Clin Pract. 2024;207:111087.
    PubMed         Abstract available

  15. SAGNA Y, Bagbila WPAH, Sawadogo N, Savadogo PPC, et al
    Incidence, prevalence, and mortality of type 1 diabetes in children and youth in Burkina Faso 2013-2022.
    Diabetes Res Clin Pract. 2024;207:111086.
    PubMed         Abstract available

  16. KARI K, Thayani Z, Ward S, Magee T, et al
    Assessing the uptake of the type 1 diabetes core outcome set in randomized controlled trials: A Cross-Sectional study.
    Diabetes Res Clin Pract. 2024;207:111085.
    PubMed         Abstract available

  17. SIBIAK R, Mantaj U, Gutaj P, Richard Law G, et al
    Functional analysis of daily glycemic profiles and excessive fetal growth in pregnant patients with well-controlled type 1 diabetes: Retrospective cohort.
    Diabetes Res Clin Pract. 2024;207:111088.
    PubMed         Abstract available


    Intern Med

  18. OKUBO S, Mano T, Sudo A, Goto R, et al
    Anti-neurofascin 155 Antibody-positive Neuropathy in a Human Immunodeficiency Virus-infected Patient.
    Intern Med. 2024;63:565-569.
    PubMed         Abstract available

  19. KAMIJO K
    Shift in Dominance from Blocking to Stimulating Type of Thyrotropin Receptor Antibodies, Resulting in Conversion from Hypothyroidism to Hyperthyroidism during Late Pregnancy.
    Intern Med. 2024;63:521-526.
    PubMed         Abstract available

  20. ASHIZAWA N, Kubo R, Tagawa R, Ito Y, et al
    Efficacy of Intrathecal Isoniazid and Steroid Therapy in Refractory Tuberculous Meningitis.
    Intern Med. 2024;63:583-586.
    PubMed         Abstract available

  21. MORIOKA F, Nakatani S, Mori K, Naganuma T, et al
    New-onset Kidney Biopsy-proven Membranous Nephropathy Induced End-stage Kidney Disease in a Living Donor: A Case Report.
    Intern Med. 2024 Feb 12. doi: 10.2169/internalmedicine.2814.
    PubMed         Abstract available

  22. YAMAZOE M, Takeda K, Nagano Y, Nagano K, et al
    Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis with Rapidly Progressing Interstitial Lung Disease Successfully Treated by Initiation of Combined Immunosuppressive Therapy Plus Plasma Exchange and Subsequently Switching Tacrolimus to
    Intern Med. 2024 Feb 12. doi: 10.2169/internalmedicine.2915.
    PubMed         Abstract available


    J Autoimmun

  23. NEYS SFH, Heutz JW, van Hulst JAC, Vink M, et al
    Aberrant B cell receptor signaling in circulating naive and IgA(+) memory B cells from newly-diagnosed autoantibody-positive rheumatoid arthritis patients.
    J Autoimmun. 2024;143:103168.
    PubMed         Abstract available


    J Nephrol

  24. CHRISTODOULOU M, Moysidou E, Lioulios G, Stai S, et al
    The prognostic value of two histopathologic classification models of ANCA-associated glomerulonephritis: a prospective study.
    J Nephrol. 2024 Feb 12. doi: 10.1007/s40620-023-01855.
    PubMed         Abstract available


    J Neuroimmunol

  25. LOTFI A, Abbasi M, Karami N, Arghavanfar H, et al
    Effects of treadmill training on myelin proteomic markers and cerebellum morphology in a rat model of cuprizone-induced toxic demyelination.
    J Neuroimmunol. 2024;387:578286.
    PubMed         Abstract available

  26. ZHANG C, Liu R, Gao B, Li T, et al
    Efficacy and safety of low- and ultralow-dose rituximab in neuromyelitis optica spectrum disorder.
    J Neuroimmunol. 2024;387:578285.
    PubMed         Abstract available


    J Neurol

  27. HARDING KE, Kreft KL, Ben-Shlomo Y, Robertson NP, et al
    Prodromal multiple sclerosis: considerations and future utility.
    J Neurol. 2024 Feb 11. doi: 10.1007/s00415-023-12173.
    PubMed         Abstract available


    J Rheumatol

  28. TAKEUCHI T, Wakasugi N, Hashida T, Uno S, et al
    Long-term safety and effectiveness of tacrolimus in patients with lupus nephritis in Japan: 10-year analysis of the real-world TRUST study.
    J Rheumatol. 2024 Feb 15:jrheum.2023-0210. doi: 10.3899/jrheum.2023-0210.
    PubMed         Abstract available

  29. WALSH M, Strouse J, Bettendorf B
    Paget Disease as a Rare Mimicker of Giant Cell Arteritis.
    J Rheumatol. 2024 Feb 15:jrheum.2023-1160. doi: 10.3899/jrheum.2023-1160.
    PubMed         Abstract available


    Mult Scler

  30. LANGDON D
    Neuropsychological assessment in MS is outdated and in need for innovation: NO.
    Mult Scler. 2024;30:152-153.
    PubMed        

  31. HOANG P, Sturnieks DL, Butler A, Chaplin C, et al
    A custom-built step exergame training programme to prevent falls in people with multiple sclerosis: A multicentre randomised controlled trial.
    Mult Scler. 2024 Feb 16:13524585241229360. doi: 10.1177/13524585241229360.
    PubMed         Abstract available

  32. COLLONGUES N, Durand-Dubief F, Lebrun-Frenay C, Audoin B, et al
    Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society.
    Mult Scler. 2024 Feb 15:13524585231223880. doi: 10.1177/13524585231223880.
    PubMed         Abstract available

  33. PATEL S, Rafferty S, Aquino L, Chadha S, et al
    VISIBL-MS: A bilingual educational framework to increase awareness of early multiple sclerosis.
    Mult Scler. 2024 Feb 15:13524585241228739. doi: 10.1177/13524585241228739.
    PubMed         Abstract available

  34. KVISTAD CE, Lehmann AK, Kvistad SAS, Holmoy T, et al
    Autologous hematopoietic stem cell transplantation for multiple sclerosis: Long-term follow-up data from Norway.
    Mult Scler. 2024 Feb 12:13524585241231665. doi: 10.1177/13524585241231665.
    PubMed         Abstract available


    N Engl J Med

  35. HAUSER SL
    Silencing Immune Dialogue in Multiple Sclerosis.
    N Engl J Med. 2024;390:662-663.
    PubMed        

  36. VERMERSCH P, Granziera C, Mao-Draayer Y, Cutter G, et al
    Inhibition of CD40L with Frexalimab in Multiple Sclerosis.
    N Engl J Med. 2024;390:589-600.
    PubMed         Abstract available


    Neurology

  37. ARNOLD DL, Elliott C, Martin EC, Hyvert Y, et al
    Effect of Evobrutinib on Slowly Expanding Lesion Volume in Relapsing Multiple Sclerosis: A Post Hoc Analysis of a Phase 2 Trial.
    Neurology. 2024;102:e208058.
    PubMed         Abstract available

  38. CHARD DT
    Chronically Active Lesions as a Trial Outcome in Multiple Sclerosis: A New Perspective on an Old Foe.
    Neurology. 2024;102:e209246.
    PubMed        

  39. SALTER A, Lancia S, Kowalec K, Fitzgerald KC, et al
    Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations.
    Neurology. 2024;102:e209135.
    PubMed         Abstract available


    PLoS Comput Biol

  40. KENNEDY KE, Kerlero de Rosbo N, Uccelli A, Cellerino M, et al
    Multiscale networks in multiple sclerosis.
    PLoS Comput Biol. 2024;20:e1010980.
    PubMed         Abstract available


    PLoS One

  41. YANG H, Chen Z, Huang J, Li S, et al
    AWD-stacking: An enhanced ensemble learning model for predicting glucose levels.
    PLoS One. 2024;19:e0291594.
    PubMed         Abstract available

  42. DADVAR A, Jameie M, Azizmohammad Looha M, Parsaei M, et al
    Potential efficacy of caffeine ingestion on balance and mobility in patients with multiple sclerosis: Preliminary evidence from a single-arm pilot clinical trial.
    PLoS One. 2024;19:e0297235.
    PubMed         Abstract available

  43. JAKA S, Singh S, Vashist S, Pokhrel S, et al
    Pediatric anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: Exploring psychosis, related risk factors, and hospital outcomes in a nationwide inpatient sample: A cross-sectional study.
    PLoS One. 2024;19:e0296870.
    PubMed         Abstract available

  44. MITTAL R, McKenna K, Keith G, Lemos JRN, et al
    A systematic review of the association of Type I diabetes with sensorineural hearing loss.
    PLoS One. 2024;19:e0298457.
    PubMed         Abstract available

  45. SHEMIRANI F, Pingel WR, Titcomb TJ, Salari-Moghaddam A, et al
    The effect of dietary interventions on inflammatory biomarkers among people with multiple sclerosis: A protocol for systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2024;19:e0297510.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  46. IVERSEN R, Sollid LM
    Dissecting autoimmune encephalitis through the lens of intrathecal B cells.
    Proc Natl Acad Sci U S A. 2024;121:e2401337121.
    PubMed        

  47. ADAMS C, Manouchehrinia A, Quach HL, Quach DL, et al
    Evidence supports a causal association between allele-specific vitamin D receptor binding and multiple sclerosis among Europeans.
    Proc Natl Acad Sci U S A. 2024;121:e2302259121.
    PubMed         Abstract available

  48. CHEN Y, Chen K, Zhu H, Qin H, et al
    Methyltransferase Setd2 prevents T cell-mediated autoimmune diseases via phospholipid remodeling.
    Proc Natl Acad Sci U S A. 2024;121:e2314561121.
    PubMed         Abstract available


    Semin Hematol

  49. PAGLIUCA S, Ferraro F
    Immune-driven clonal cell selection at the intersection among cancer, infections, autoimmunity and senescence.
    Semin Hematol. 2024 Jan 17:S0037-1963(24)00001.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.